| Respiratory distress syndrome in the newborn: innovative therapies. | |
| | |
MedLine Citation:
|
PMID: 8430594 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Neonatal respiratory distress syndrome affects 60,000 to 70,000 infants each year in the United States. Although the mortality rate has decreased dramatically over the past 30 years, many infants die or have sequelae from the syndrome. Three innovative techniques are now playing a role in improving the course of neonates with respiratory distress syndrome: surfactant replacement therapy, high-frequency ventilation and extracorporeal membrane oxygenation. Surfactant therapy should be considered the standard of care for infants with respiratory distress syndrome who require mechanical ventilation. Further investigation is needed to define the precise roles of high-frequency ventilation and extracorporeal membrane oxygenation in the management of neonates with respiratory distress syndrome. |
| | |
Authors:
|
T E Wiswell; J Mendiola |
Related Documents
:
|
15576514 - The validity of chief complaint and discharge diagnosis in emergency department-based s... 9881394 - Ards. history, definitions, and physiology. 6452814 - Hearing loss of down syndrome adults. 2369214 - Right pneumonectomy syndrome in infancy treated with an expandable prosthesis. 3723604 - Transcultural sexology: formicophilia, a newly named paraphilia in a young buddhist male. 17457204 - Descemet stripping with endothelial keratoplasty for treatment of iridocorneal endothel... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: American family physician Volume: 47 ISSN: 0002-838X ISO Abbreviation: Am Fam Physician Publication Date: 1993 Feb |
Date Detail:
|
Created Date: 1993-03-09 Completed Date: 1993-03-09 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 1272646 Medline TA: Am Fam Physician Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 407-14 Citation Subset: AIM; IM |
Affiliation:
|
Walter Reed Army Medical Center, Washington, DC. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Extracorporeal Membrane Oxygenation* High-Frequency Ventilation* Humans Infant, Newborn Pulmonary Surfactants / therapeutic use* Respiratory Distress Syndrome, Newborn / therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Pulmonary Surfactants |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Interpreting the mammogram report.
Next Document: Endovascular surgery for peripheral arterial occlusive disease.